Skip to content

All recalls FDA

FDADrugsRecalled Status: Completed

Sun Pharmaceutical Industries Inc recalls Mesalamine Delayed-Release Tablets

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
Products
  • Mesalamine Delayed-Release Tablets
Where it was sold

Nationwide in the USA

Nationwide

Units affected
10,690 bottles
About this recall
Mesalamine Delayed-Release Tablets, USP 1.2 g per tablet, Rx Only, 120 Tablets per bottle, Once Daily, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited Survey No. 259/15, Dadra-396 191 (U.T. of D & NH), INDIA, NDC 63304-175-13.